Make Medicines Affordable · Episode

A technical briefer sharing gaps and access priorities to ensure access to right diagnostics for Bundibugyo Ebola virus outbreak in DRC and Uganda.

Alors que des milliers de personnes fuyant la guerre au Soudan se réfugient dans l’est du Tchad, les équipes de Médecins Sans Frontières (MSF) font face à une double épidémie de rougeole et de méningi...

Lenacapavir, almost 100% effective at preventing HIV, is priced by Gilead at $28,200 and inaccessible to many in low-income countries plagued by the disease.

Lenacapavir, almost 100% effective at preventing HIV, is priced by Gilead at $28,200 and inaccessible to many in low-income countries plagued by the disease.

BOLSTERING NATIONAL SECURITY: Today, President Donald J. Trump imposed tariffs on patented pharmaceuticals and their ingredients under Section 232 of the

The move came after months of talks in which Doctors Without Borders asked Gilead Sciences for a “limited” supply of lenacapavir.

MSF calls on Gilead for direct access to lenacapavir, as the current rollout falls far short of the needs.

MSF calls on Gilead for direct access to lenacapavir, as the current rollout falls far short of the needs.

Blocking humanitarian organizations from accessing a medical breakthrough puts vulnerable people across the world in danger.